News

Fierce Biotech20h
Scancell picks winner from phase 2 cancer vaccine face-off, choosing next-gen prospect for pivotal trial
Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...
Fierce Biotech14h
Korean CRO CorestemChemon inks collaboration to expand into organoids and transcriptomics
Korean preclinical CRO CorestemChemon is expanding its offerings through a partnership with ATG Lifetech, with the goal of ...
Fierce Biotech17h
FDA amplifies neurosurgery kit recall efforts at Medline, Integra
The FDA is amplifying an effort underway at medical device distributor Medline that aims to correct certain neurosurgery kits ...
Fierce Biotech21h
Replimune's shares crater as FDA rejects melanoma drug
The FDA has rejected Replimune’s request for approval of RP1, adding the melanoma drug candidate to the list of assets to ...
Fierce Biotech16h
Hyperfine begins rolling out its next-gen MRI scanner-on-wheels
The portable MRI manufacturer Hyperfine has begun rolling out the next generation of its artificial intelligence-equipped scanner-on-wheels, following an FDA green light last month.  | The Fierce ...